A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
A5320/V-HICS is an observational, prospective, long-term follow-up study in hepatitis C virus (HCV) monoinfected and HCV/HIV-1...
